Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories
The Journal of Infectious Diseases · 08.05.2024 · 229 (Supplement_3) · S357-S361
DOI: 10.1093/infdis/jiad191 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 22.09.2023. Verfasst von Lauren N Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Association of Public Health Laboratories, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: RNA, Viral, Hepatitis C, Hepacivirus, Hepatitis C Antibodies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection can have serious consequences when untreated and diagnosis is the first step in any treatment regimen. In the Unites States a 2-step algorithm consisting of HCV antibody screening and HCV RNA testing of HCV antibody-reactive specimens is recommended for detection of current HCV infection. We conducted a survey of HCV diagnostic practices in US public health laboratories and convened a meeting of HCV subject matter experts to identify opportunities for improvement in HCV diagnosis. Automatic reflexive HCV RNA testing of HCV antibody-reactive specimens was identified as a gap in laboratory practice. Only 54% of respondent laboratories always automatically reflexed or referred an anti-HCV-reactive specimen to an HCV RNA test. To facilitate diagnosis and ensure patients are not lost to follow-up, laboratories should ensure that the entire HCV testing algorithm can be completed with a sample(s) collected during a single patient visit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Association of Public Health Laboratories, Silver Spring, Maryland, USA.
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Johnson, L. N., Gaynor, A. M., Wroblewski, K., & Buss, S. N. (2024). Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories. The Journal of Infectious Diseases, 229(Supplement_3), S357-S361. https://doi.org/10.1093/infdis/jiad191
Vancouver
Johnson LN, Gaynor AM, Wroblewski K, Buss SN. Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories. The Journal of Infectious Diseases. 2024;229(Supplement_3):S357-S361. doi:10.1093/infdis/jiad191
BibTeX
@article{Johnson2024,
author = {Johnson, Lauren N and Gaynor, Anne M and Wroblewski, Kelly and Buss, Sarah N},
title = {Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {229},
number = {Supplement_3},
pages = {S357--S361},
doi = {10.1093/infdis/jiad191}
}
EUVIMED